VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 210 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $171,000 | -45.0% | 18,257 | +44.0% | 0.00% | – |
| Q2 2023 | $311,000 | +49.5% | 12,678 | +41.4% | 0.00% | – |
| Q1 2023 | $208,000 | -42.2% | 8,965 | -36.9% | 0.00% | – |
| Q4 2022 | $360,000 | +355.7% | 14,198 | +244.2% | 0.00% | – |
| Q3 2022 | $79,000 | -14.1% | 4,125 | +14.1% | 0.00% | – |
| Q2 2022 | $92,000 | -73.0% | 3,615 | -72.7% | 0.00% | – |
| Q1 2022 | $341,000 | -41.7% | 13,253 | -5.2% | 0.00% | – |
| Q4 2021 | $585,000 | +5218.2% | 13,978 | +5491.2% | 0.00% | – |
| Q3 2021 | $11,000 | -8.3% | 250 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -90.1% | 250 | -89.4% | 0.00% | – |
| Q1 2021 | $121,000 | +2925.0% | 2,368 | +1427.7% | 0.00% | – |
| Q4 2020 | $4,000 | -33.3% | 155 | -11.9% | 0.00% | – |
| Q3 2020 | $6,000 | -40.0% | 176 | -29.6% | 0.00% | – |
| Q2 2020 | $10,000 | +42.9% | 250 | +15.7% | 0.00% | – |
| Q1 2020 | $7,000 | +16.7% | 216 | -57.1% | 0.00% | – |
| Q4 2019 | $6,000 | – | 503 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |